These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34994040)

  • 1. Segmental vitiligo following acitretin treatment for infantile generalized pustular psoriasis resulting in repigmentation under secukinumab therapy.
    Yang Y; Xu Q; Zhang Z; Yao Z
    Dermatol Ther; 2022 Apr; 35(4):e15305. PubMed ID: 34994040
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
    Miao C; Chen Y; Wang Z; Xiang X; Liu Y; Xu Z
    J Dermatol; 2023 Feb; 50(2):258-261. PubMed ID: 35983654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.
    Li J; Wang S; Li XD; Han Y
    J Int Med Res; 2024 Apr; 52(4):3000605241247702. PubMed ID: 38661102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile.
    Polat Ekinci A; Bölük KN; Babuna Kobaner G
    Dermatol Ther; 2021 Jan; 34(1):e14704. PubMed ID: 33368934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of vitiligo in a psoriasis patient on ixekizumab.
    Marasca C; Fornaro L; Martora F; Picone V; Fabbrocini G; Megna M
    Dermatol Ther; 2021 Sep; 34(5):e15102. PubMed ID: 34436817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secukinumab-induced vitiligo: A new case report and review of the literature.
    Bouzid S; Hammami-Ghorbel H; Chamli A; Aounti I; Daly W; Kochbati S; Fenniche S; Zaouak A
    Therapie; 2023; 78(6):754-756. PubMed ID: 36566160
    [No Abstract]   [Full Text] [Related]  

  • 7. Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation?
    Martora F; Battista T; Fornaro L; Fabbrocini G; Megna M; Picone V; Marasca C
    Dermatol Ther; 2022 Dec; 35(12):e15874. PubMed ID: 36181259
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitiligo development in a patient with psoriasis vulgaris treated with ixekizumab.
    Eker H; Kaya İslamoğlu ZG; Demirbaş A
    Dermatol Ther; 2022 Apr; 35(4):e15314. PubMed ID: 35019197
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitiligo Repigmentation with Melanoma Progression During Pembrolizumab Treatment.
    Nardin C; Pelletier F; Puzenat E; Aubin F
    Acta Derm Venereol; 2019 Sep; 99(10):913-914. PubMed ID: 31017249
    [No Abstract]   [Full Text] [Related]  

  • 10. Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report.
    Guevara BEK; Aquino JMRM; Diaz RBS; Contreras AIT; Jeng YC; Huang HY; Hsu CK; Pandita-Reyes BSB
    Exp Dermatol; 2023 Aug; 32(8):1296-1298. PubMed ID: 36847294
    [No Abstract]   [Full Text] [Related]  

  • 11. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.
    Gallo E; Llamas-Velasco M; Daudén E; García-Diez A
    Int J Dermatol; 2013 Dec; 52(12):1610-1. PubMed ID: 22834488
    [No Abstract]   [Full Text] [Related]  

  • 12. Generalized pustular psoriasis treated with ustekinumab.
    Storan ER; O'Gorman SM; Markham T
    Clin Exp Dermatol; 2016 Aug; 41(6):689-90. PubMed ID: 27333948
    [No Abstract]   [Full Text] [Related]  

  • 13. Excellent response to secukinumab in an infant with severe generalized pustular psoriasis.
    López-Sánchez C; Falla LM; Roé-Crespo E; Arostegui JI; Mozos A; Bernal S; Iznardo H; Baselga-Torres E
    J Dermatol; 2021 Jun; 48(6):907-910. PubMed ID: 33543522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acitretin is a safe treatment option for infantile pustular psoriasis.
    Ergin S; Ersoy-Evans S; Sahin S; Ozkaya O
    J Dermatolog Treat; 2008; 19(6):341-3. PubMed ID: 18608713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acitretin.
    Ortiz NE; Nijhawan RI; Weinberg JM
    Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repigmentation of acrofacial vitiligo with subcutaneous tildrakizumab.
    Jerjen R; Moodley A; Sinclair R
    Australas J Dermatol; 2020 Nov; 61(4):e446-e448. PubMed ID: 32441048
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice.
    Reymundo A; Vilarrasa E; Baniandrés O; Rodríguez-Fernández-Freire L; Feltes R; Llamas-Velasco M; Daudén E
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e849-e851. PubMed ID: 35689497
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythroderma in a patient taking acitretin for plaque psoriasis.
    Ahdout J; Mandel H; Chiu M
    J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized vitiligo in a psoriatic patient treated with ixekizumab.
    Pathmarajah P; Benjamin-Laing Z; Abdurrahman M; Grunova A; Sinclair C
    Dermatol Ther; 2022 Dec; 35(12):e15872. PubMed ID: 36181252
    [No Abstract]   [Full Text] [Related]  

  • 20. Acitretin induces capillary leak syndrome in a patient with pustular psoriasis.
    Vos LE; Vermeer MH; Pavel S
    J Am Acad Dermatol; 2007 Feb; 56(2):339-42. PubMed ID: 17097361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.